Peroxisomal ABC transporters and X-linked adrenoleukodystrophy

被引:3
|
作者
Geillon, Flore [1 ]
Trompier, Doriane [1 ]
Gondcaille, Catherine [1 ]
Lizard, Gerard [1 ]
Savary, Stephane [1 ]
机构
[1] Univ Bourgogne, Lab BioperoxIL Biochim Peroxysome Inflammat & Met, EA7270, F-21000 Dijon, France
来源
M S-MEDECINE SCIENCES | 2012年 / 28卷 / 12期
关键词
CHAIN FATTY-ACID; MOUSE MODEL; ASYMPTOMATIC PATIENTS; AXONAL DEGENERATION; GENE-THERAPY; ALD; INDUCTION; PROTEIN; ACCUMULATION;
D O I
10.1051/medsci/20122812019
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Peroxisomal ABC transporters and X-linked adrenoleukodystrophy X-linked adrenoleukodystrophy (X-ALD) is a complex neurodegenerative disease associated with mutations in the ABCD1 gene, which encodes for a peroxisomal ABC transporter. Thanks to the efforts of the ELA foundation and to the recent successes of gene therapy published in Science in 2009, X-ALD is better known but still remains poorly understood. The exact role of ABCD1 and its homologs, as well as the exact link between the biochemical and metabolic peroxisomal defects and the clinical symptoms of the disease remain to be elucidated. This review summarizes the knowledge concerning the subfamily D of the ABC transporter family and concerning X-ALD, the most frequent peroxisomal disorder.
引用
收藏
页码:1087 / 1094
页数:8
相关论文
共 50 条
  • [1] Pathophysiology of X-linked adrenoleukodystrophy
    Berger, J.
    Forss-Petter, S.
    Eichler, F. S.
    BIOCHIMIE, 2014, 98 : 135 - 142
  • [2] Impaired mitochondrial oxidative phosphorylation in the peroxisomal disease X-linked adrenoleukodystrophy
    Lopez-Erauskin, J.
    Galino, J.
    Ruiz, M.
    Cuezva, J. M.
    Fabregat, I.
    Cacabelos, D.
    Boada, J.
    Martinez, J.
    Ferrer, I.
    Pamplona, R.
    Villarroya, F.
    Portero-Otin, M.
    Fourcade, S.
    Pujol, A.
    HUMAN MOLECULAR GENETICS, 2013, 22 (16) : 3296 - 3305
  • [3] Glutathione imbalance in patients with X-linked adrenoleukodystrophy
    Petrillo, Sara
    Piemonte, Fiorella
    Pastore, Anna
    Tozzi, Giulia
    Aiello, Chiara
    Pujol, Aurora
    Cappa, Marco
    Bertini, Enrico
    MOLECULAR GENETICS AND METABOLISM, 2013, 109 (04) : 366 - 370
  • [4] X-linked adrenoleukodystrophy
    Aubourg, P.
    ANNALES D ENDOCRINOLOGIE, 2007, 68 (06) : 403 - 411
  • [5] Translational and clinical pharmacology considerations in drug repurposing for X-linked adrenoleukodystrophy-A rare peroxisomal disorder
    Tieu, Julianne H.
    Sahasrabudhe, Siddhee A.
    Orchard, Paul J.
    Cloyd, James C.
    Kartha, Reena V.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 88 (06) : 2552 - 2563
  • [6] Oxidative Stress in Patients with X-Linked Adrenoleukodystrophy
    Deon, Marion
    Marchetti, Desiree P.
    Donida, Bruna
    Wajner, Moacir
    Vargas, Carmen
    CELLULAR AND MOLECULAR NEUROBIOLOGY, 2016, 36 (04) : 497 - 512
  • [7] General Aspects and Neuropathology of X-Linked Adrenoleukodystrophy
    Ferrer, Isidro
    Aubourg, Patrick
    Pujol, Aurora
    BRAIN PATHOLOGY, 2010, 20 (04) : 817 - 830
  • [8] Valproic acid induces antioxidant effects in X-linked adrenoleukodystrophy
    Fourcade, Stephane
    Ruiz, Montserrat
    Guilera, Cristina
    Hahnen, Eric
    Brichta, Lars
    Naudi, Alba
    Portero-Otin, Manuel
    Dacremont, Georges
    Cartier, Nathalie
    Wanders, Ronald
    Kemp, Stephan
    Mandel, Jean Louis
    Wirth, Brunhilde
    Pamplona, Reinald
    Aubourg, Patrick
    Pujol, Aurora
    HUMAN MOLECULAR GENETICS, 2010, 19 (10) : 2005 - 2014
  • [9] X-Linked Adrenoleukodystrophy: Pathogenesis and Treatment
    Engelen, Marc
    Kemp, Stephan
    Poll-The, Bwee-Tien
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2014, 14 (10) : 1 - 8
  • [10] Antioxidant Response in Human X-Linked Adrenoleukodystrophy Fibroblasts
    Petrillo, Sara
    D'Amico, Jessica
    Nicita, Francesco
    Torda, Caterina
    Vasco, Gessica
    Bertini, Enrico S.
    Cappa, Marco
    Piemonte, Fiorella
    ANTIOXIDANTS, 2022, 11 (11)